Nucleate Podcast

Translating Science into Patient Impact with Kendra Rose

Episode Summary

In this episode we are joined by Kendra Rose, Senior Vice President of BD&L at Bayer, who brings a blend of scientific depth and business acumen to the conversation. Her journey began with a passion for science which led her to pursue a Ph.D. in chemistry at Stanford University, before making a pivot to take her expertise into industry and joining Johnson & Johnson, then Novartis, and now Bayer. Kendra reflects on the lessons that have shaped her career and offers advice for early-stage founders and scientists considering a similar path. The conversation covers everything from understanding consumer needs to the latest trends driving healthcare innovation. She also offers a look into the Bayer Co.Lab incubator ecosystem, sharing insights on what it takes to succeed in a competitive market.

Episode Notes

Time Stamps:

(2:37) Introduction to Kendra’s professional journey and how she found her path into science 

(7:30) Understanding the consumer mindset and patient perspectives

(13:05) Key parameters that shape important decisions 

(17:45) Core lessons on bridging the gap between science and business 

(25:30) Introduction to Bayer and Kendra’s  role as Senior Vice President of Business Development and Licensing 

(29:46) Latest trends shaping healthcare research,  education, and innovation 

(38:59) How to establish credibility as an entrepreneur in a competitive market

(41:28) Inside the Bayer Co.Lab incubator ecosystem and the support it offers

(50:37) Tips for early-career scientists interested in making a pivot from the lab to business

(57:09) Do you really need a Ph.D. to break into pharma?

(1:00:01) Quick fire questions